Literature DB >> 12777958

Why is hypertension so frequently uncontrolled in secondary prevention?

Jacques Amar1, Bernard Chamontin, Nathalie Genes, Christelle Cantet, Michel Salvador, Jean Pierre Cambou.   

Abstract

OBJECTIVE: To analyze blood pressure (BP) control in secondary prevention.
DESIGN: Individual data of two cross-sectional studies on preventive cardiology (PRATIK and ESPOIR studies conducted, respectively, in general practice and with private cardiologists) were analyzed.
SETTING: Primary care. PARTICIPANTS: Patients both with treated hypertension and coronary disease. MAIN OUTCOME MEASURES: Risk factors, treatments, cardiovascular history and BP were recorded. Each population was divided in three groups: group I, no other risk factor; group II, one or two risk factors; group III, three or more risk factors or diabetes.
RESULTS: A total of 1423 and 2596 patients, respectively, recruited in general practice and by cardiologists were analyzed. Of these, 473 (33.24%) and 1060 (40.83%) patients, respectively, had controlled hypertension. Among uncontrolled hypertensives, more than 50% had borderline isolated systolic hypertension. Associated risk factors negatively affect hypertension control, which had been achieved in a lower percentage of patients in group III than in group I (general practice, 26.28 versus 42.20%; cardiological practice, 32.42 versus 56.13%). In general practice, the percentage of patients receiving beta-blockers was significantly lower in group III. Among individuals with uncontrolled hypertension, only 17.58 and 26.69% received at least three-drug treatment including diuretics in general and in cardiological practice, respectively.
CONCLUSION: The negative influence of associated risk factors and the under-use of combination therapy contribute to poor BP control. In addition the high frequency of borderline isolated systolic hypertension suggests that the prerequisite to improve hypertension control should be to convince practitioners of the beneficial effect of tight systolic BP control (below 140 mmHg) in secondary prevention.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12777958     DOI: 10.1097/00004872-200306000-00021

Source DB:  PubMed          Journal:  J Hypertens        ISSN: 0263-6352            Impact factor:   4.844


  11 in total

Review 1.  Hypertension Survey in Italy: Novel Findings from the Campania Salute Network.

Authors:  Eugenio Stabile; Raffaele Izzo; Francesco Rozza; Maria Angela Losi; Nicola De Luca; Bruno Trimarco
Journal:  High Blood Press Cardiovasc Prev       Date:  2017-07-01

Review 2.  Treatment strategies for resistant arterial hypertension.

Authors:  Felix Mahfoud; Frank Himmel; Christian Ukena; Heribert Schunkert; Michael Böhm; Joachim Weil
Journal:  Dtsch Arztebl Int       Date:  2011-10-28       Impact factor: 5.594

3.  Assessment of drug-related problems and their impact on blood pressure control in patients with hypertension.

Authors:  Rana Abu Farha; Iman Basheti; Hassan Abu Al Ruz; Akram Alsaleh; Salah AbuRuz
Journal:  Eur J Hosp Pharm       Date:  2015-10-16

4.  Knowledge and Implementation of the New European Guide in the Management of Arterial Hypertension. The Cigema Survey.

Authors:  Leopoldo Pérez de Isla; Luis Miguel Ruilope; Alejandro De la Sierra; José Zamorano
Journal:  Pharmaceuticals (Basel)       Date:  2009-07-28

5.  The efficacy and safety of low- and high-dose fixed combinations of irbesartan/hydrochlorothiazide in patients with uncontrolled systolic blood pressure on monotherapy: the INCLUSIVE trial.

Authors:  Joel M Neutel; Elijah Saunders; George L Bakris; William C Cushman; Keith C Ferdinand; Elizabeth O Ofili; James R Sowers; Michael A Weber
Journal:  J Clin Hypertens (Greenwich)       Date:  2005-10       Impact factor: 3.738

6.  Relationship between blood pressure measurements recorded on patients' charts in family physicians' offices and subsequent 24 hour ambulatory blood pressure monitoring.

Authors:  Marshall Godwin; Dianne Delva; Rachelle Seguin; Ian Casson; Susan MacDonald; Richard Birtwhistle; Miu Lam
Journal:  BMC Cardiovasc Disord       Date:  2004-03-29       Impact factor: 2.298

Review 7.  Summary of the 2007 European Society of Hypertension (ESH) and European Society of Cardiology (ESC) guidelines for the management of arterial hypertension.

Authors: 
Journal:  Vasc Health Risk Manag       Date:  2007

Review 8.  Treating resistant hypertension: role of renal denervation.

Authors:  Daniel Urban; Sebastian Ewen; Christian Ukena; Dominik Linz; Michael Böhm; Felix Mahfoud
Journal:  Integr Blood Press Control       Date:  2013-09-11

9.  Uptitrating amlodipine significantly reduces blood pressure in diabetic patients with hypertension: a retrospective, pooled analysis.

Authors:  Barrett W Jeffers; Rahul Bhambri; Jeffery Robbins
Journal:  Vasc Health Risk Manag       Date:  2014-11-14

10.  The relation between health insurance and management of hypertension in Shanghai, China: a cross-sectional study.

Authors:  Xinji Zhang; Yuan Zhang; Xiang Xiao; Xiuqiang Ma; Jia He
Journal:  BMC Public Health       Date:  2016-09-10       Impact factor: 3.295

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.